A detailed history of Bridgefront Capital, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 10,901 shares of CLBT stock, worth $258,353. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,901
Holding current value
$258,353
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.61 - $17.52 $126,560 - $190,985
10,901 New
10,901 $183,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.49B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.